J Korean Med Sci.  2014 Jul;29(7):1012-1017. 10.3346/jkms.2014.29.7.1012.

A Case Report of Preoperative and Postoperative 7.0T Brain MRI in a Patient with a Small Cell Glioblastoma

Affiliations
  • 1Department of Neurosurgery, Seoul National University Hospital, Cancer Research Institute, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Korea. paeksh@snu.ac.kr
  • 2Department of Radiology, Seoul National University Hospital, Cancer Research Institute, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Korea.
  • 3Department of Pathology, Seoul National University Hospital, Cancer Research Institute, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Korea.
  • 4Neuroscience Research Institute, Gachon University of Medicine and Science, Incheon, Korea.

Abstract

A 45-yr-old female patient was admitted with one-month history of headache and progressive left hemiparesis. Brain magnetic resonance imaging (MRI) demonstrated a mass lesion in her right frontal lobe. Her brain tumor was confirmed as a small cell glioblastoma. Her follow-up brain MRI, taken at 8 months after her initial surgery demonstrated tumor recurrence in the right frontal lobe. Contrast-enhanced 7.0T brain magnetic resonance imaging (MRI) was safely performed before surgery and at the time of recurrence. Compared with 1.5T and 3.0T brain MRI, 7.0T MRI showed sharpened images of the brain tumor contexture with detailed anatomical information. The fused images of 7.0T and 1.5T brain MRI taken at the time of recurrence demonstrated no significant discrepancy in the positions of the anterior and the posterior commissures. It is suggested that 7.0T MRI can be safely utilized for better images of the maligant gliomas before and after surgery.

Keyword

Pre- and post-operative 7.0T MRI; Small Cell Glioblastoma

MeSH Terms

Brain Neoplasms/pathology/*radiography/surgery
Female
Frontal Lobe/radiography
Glioblastoma/pathology/*radiography/surgery
Humans
In Situ Hybridization, Fluorescence
*Magnetic Resonance Imaging
Middle Aged
Neoplasm Recurrence, Local
Receptor, Epidermal Growth Factor/genetics
Receptor, Epidermal Growth Factor

Figure

  • Fig. 1 Brain MRIs taken before surgery in a patient with small cell glioblastoma. Axial T2-WI of 1.5T (A), 3.0T (B), and T2*-WI of 7.0T (C) brain MRIs with their four-times magnified images (A', B', and C') of quadri-angular areas demonstrate a multi-cystic mass lesion in the right fronto-parietal lobe. Irregular areas of heterogeneous signal intensity in the tumor area were best displayed on T2*-WI of 7.0T (C and C') brain MRI, presumably representing hemorrhage or tumor microvasculature. Coronal T1WI of 1.5T (D) and 7.0T (E) brain MRIs with their four-times magnified images (D' and E') of quadric-angular areas show a ill-defined subcortical mass lesion in the right parietal lobe. The contrast-enhanced T1WI of 1.5T (F) and 7.0T (G) brain MRIs with their four-times magnified images (F' and G') demonstrate irregularly rim-enhancing mass lesion in the right parietal lobe. A rim-enhancing mass lesion is more clearly defined with sharp margin from the surrounding compressed brain cortex in 7.0T brain MRI (G and G').

  • Fig. 2 Postoperative skull AP (A) and lateral (B) views show the midline-crossing right fronto-parietal craniotomy site. H&E staining shows typical findings of a small cell glioblastoma composed of less pleomorphic small astrocytic cells with high mitotic rate (6/10HPF), vascular endothelial hyperplasia, and necrosis (C, magnification×200) and the fluorescence in situ hybridization study of the tumor shows amplification of epidermal growth factor receptor (EGFR) gene (D, magnification×200).

  • Fig. 3 1.5T and 7.0T brain MRIs taken at the time of recurrence in a patient with small cell glioblastoma, 8 months after the initial surgery. T2WI and T1WI with contrast enhancement of 1.5T brain MRI (A, B, C) and 7.0T brain MRI (D, E, F) show a new enhancing mass lesion in the right frontal lobe. More enhanced anatomical details of the brain tumor with surrounding normal structures are provided by 7.0 T MRI. The anterior commissure (AC) and posterior commissure (PC) are marked with cross lines in the fused images of contrast-enhanced axial T1-WI of 1.5T (G and H) and 7.0T (I and J) MRI at the time of tumor recurrence, taken 8 months after initial brain surgery. Images of the 7.0T and 1.5T MPRAGE gadolinium-enhanced T1-weighted MRI are co-registered by using a software, OnDemand3D™ (CyberMed, Seoul). All images are realigned to midsagittal AC-PC line. In the co-registered images of the 7.0T MRI and 1.5T MRI, there is no significant difference in the location of the AC and PC between 1.5T (G and H) and 7.0T (I and J) brain MRI taken at the time of recurrence . Difference between locations of AC measured in 1.5T and 7.0T image sets was 0.66±0.13 mm and PC was 0.62±0.08 mm.


Reference

1. Abduljalil AM, Schmalbrock P, Novak V, Chakeres DW. Enhanced gray and white matter contrast of phase susceptibility-weighted images in ultra-high-field magnetic resonance imaging. J Magn Reson Imaging. 2003; 18:284–290.
2. Thomas DL, De Vita E, Roberts S, Turner R, Yousry TA, Ordidge RJ. High-resolution fast spin echo imaging of the human brain at 4.7 T: implementation and sequence characteristics. Magn Reson Med. 2004; 51:1254–1264.
3. Norris DG. High field human imaging. J Magn Reson Imaging. 2003; 18:519–529.
4. Cha S, Johnson G, Wadghiri YZ, Jin O, Babb J, Zagzag D, Turnbull DH. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med. 2003; 49:848–855.
5. Lupo JM, Banerjee S, Hammond KE, Kelley DA, Xu D, Chang SM, Vigneron DB, Majumdar S, Nelson SJ. GRAPPA-based susceptibility-weighted imaging of normal volunteers and patients with brain tumor at 7 T. Magn Reson Imaging. 2009; 27:480–488.
6. Moenninghoff C, Maderwald S, Theysohn JM, Kraff O, Ladd ME, El Hindy N, van de Nes J, Forsting M, Wanke I. Imaging of adult astrocytic brain tumours with 7 T MRI: preliminary results. Eur Radiol. 2010; 20:704–713.
7. Kollia K, Maderwald S, Putzki N, Schlamann M, Theysohn JM, Kraff O, Ladd ME, Forsting M, Wanke I. First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. AJNR Am J Neuroradiol. 2009; 30:699–702.
8. Paek SL, Chung YS, Paek SH, Hwang JH, Sohn CH, Choi SH, Son YD, Kim YB, Kim DG, Lee KH, et al. Early experience of pre- and post-contrast 7.0T MRI in brain tumors. J Korean Med Sci. 2013; 28:1362–1372.
9. Takeda T, Takeda A, Nagaoka T, Kunieda E, Takemasa K, Watanabe M, Hatou T, Oguro S, Katayama M. Gadolinium-enhanced three-dimensional magnetization-prepared rapid gradient-echo (3D MP-RAGE) imaging is superior to spin-echo imaging in delineating brain metastases. Acta Radiol. 2008; 49:1167–1173.
10. Abduljalil AM, Robitaille PM. Macroscopic susceptibility in ultra high field MRI. J Comput Assist Tomogr. 1999; 23:832–841.
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr